SIRT1 (Sirtuin 1) Protein
Overview
SIRT1 (Sirtuin 1) is an NAD+-dependent class III histone deacetylase (HDAC) of approximately 81 kDa that functions as a master regulator of cellular stress responses, metabolism, aging, and longevity. As a highly conserved NAD+-dependent deacetylase, SIRT1 removes acetyl groups from lysine residues on histones and numerous non-histone proteins, thereby modulating gene expression, protein function, and cellular homeostasis. In the nervous system, SIRT1 plays critical roles in neuronal survival, synaptic plasticity, memory formation, and has emerged as a significant protective factor in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [Huntington's disease](/diseases/huntingtons), and other neurodegenerative disorders[@haigis2006][@kim2007].
SIRT1 belongs to the sirtuin family of proteins, which are evolutionarily conserved from yeast to humans and require NAD+ as an essential cofactor. This NAD+ dependence links SIRT1 activity directly to cellular energy status and metabolic state, making it a unique therapeutic target at the intersection of metabolism and neurodegeneration.
...SIRT1 (Sirtuin 1) Protein
Overview
SIRT1 (Sirtuin 1) is an NAD+-dependent class III histone deacetylase (HDAC) of approximately 81 kDa that functions as a master regulator of cellular stress responses, metabolism, aging, and longevity. As a highly conserved NAD+-dependent deacetylase, SIRT1 removes acetyl groups from lysine residues on histones and numerous non-histone proteins, thereby modulating gene expression, protein function, and cellular homeostasis. In the nervous system, SIRT1 plays critical roles in neuronal survival, synaptic plasticity, memory formation, and has emerged as a significant protective factor in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [Huntington's disease](/diseases/huntingtons), and other neurodegenerative disorders[@haigis2006][@kim2007].
SIRT1 belongs to the sirtuin family of proteins, which are evolutionarily conserved from yeast to humans and require NAD+ as an essential cofactor. This NAD+ dependence links SIRT1 activity directly to cellular energy status and metabolic state, making it a unique therapeutic target at the intersection of metabolism and neurodegeneration.
<div class="infobox infobox-protein">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">SIRT1 (Sirtuin 1)</th></tr>
<tr><td><strong>Protein Name</strong></td><td>SIRT1 (NAD-dependent deacetylase Sirtuin-1)</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>SIRT1</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/Q96EB6">Q96EB6</a></td></tr>
<tr><td><strong>PDB Structures</strong></td><td>4IG0, 1ZC4, 5B2R, 5Y3F</td></tr>
<tr><td><strong>Molecular Weight</strong></td><td>81 kDa</td></tr>
<tr><td><strong>Amino Acids</strong></td><td>747</td></tr>
<tr><td><strong>Subcellular Localization</strong></td><td>Nucleus, Cytoplasm (shuttles between compartments)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Sirtuin family (Class III HDACs)</td></tr>
<tr><td><strong>Brain Expression</strong></td><td>High in cortex, hippocampus, cerebellum, hypothalamus</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/alzheimer's-disease" style="color:#ef9a9a">ALZHEIMER'S DISEASE</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a></td>
</tr>
<tr>
<td class="label">SciDEX Hypotheses</td>
<td><a href="/hypothesis/h-4bb7fd8c" style="color:#ce93d8" title="Score: 0.62">Nutrient-Sensing Epigenetic Circuit Reac...</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1862 edges</a></td>
</tr>
</table>
</div>
Structure and Biochemistry
Catalytic Domain Architecture
SIRT1 possesses a modular structure optimized for its NAD+-dependent deacetylase activity[@bonkowski2014]:
- N-terminal region: Contains a flexible regulatory domain with nuclear localization signals (NLS) and binding sites for various activators and inhibitors. This region also contains sites for post-translational modifications that regulate SIRT1 activity.
- Catalytic core: The conserved Rossmann fold (~275 amino acids) comprises the enzymatic center, containing the NAD+-binding pocket and the substrate-binding groove. The active site features a conserved catalytic triad (His-363, Asn-395, His-402 in human SIRT1) that facilitates the deacetylation reaction.
- C-terminal region: A regulatory element that auto-inhibits catalytic activity through intramolecular interactions. This region can be cleaved by caspases, generating a truncated active form.
NAD+ Dependency and Mechanistic Insights
The unique NAD+ requirement of SIRT1 distinguishes it from classical HDACs:
- NAD+ binding: SIRT1 binds NAD+ in a conserved pocket, with binding affinity modulated by cellular NAD+/NADH ratios
- Deacetylation reaction: The mechanism involves formation of a covalent intermediate with ADP-ribose, followed by deacetylation and release of O-acetyl-ADP-ribose
- Metabolic coupling: Because NAD+ levels decline with age and in neurodegenerative diseases, SIRT1 activity provides a direct link between cellular metabolic state and gene regulation
Post-Translational Regulation
SIRT1 activity is regulated by multiple post-translational mechanisms:
- Phosphorylation: Multiple kinases (CK2, DYRK1A) phosphorylate SIRT1, modulating its activity
- Sumoylation: Sumoylation can enhance SIRT1 stability and activity
- Methylation: SETD7 methylates SIRT1, promoting its nuclear export
- Proteolytic processing: Caspase cleavage generates a truncated active form
Normal Function in the Nervous System
Epigenetic Regulation
SIRT1 functions as a major epigenetic regulator in the brain[@albani2014]:
- Histone deacetylation: Deacetylates H3K9, H3K14, H4K16 at promoter regions, creating a compact chromatin state that represses transcription
- Chromatin remodeling: Recruits and interacts with other chromatin-modifying complexes (e.g., SUV39H1, HDAC1/2) to coordinate epigenetic changes
- Gene-specific targeting: Directed to specific gene promoters through interactions with transcription factors, enabling context-specific regulation
SIRT1 integrates metabolic signals to regulate cellular energy homeostasis[@houtkooper2012]:
- PGC-1α activation: Deacetylates and activates PGC-1α (PPARGC1A), the master regulator of mitochondrial biogenesis
- FOXO deacetylation: Deacetylates FOXO transcription factors, shifting their activity toward antioxidant gene expression
- AMPK activation: SIRT1 activation can lead to AMPK activation, creating a positive feedback loop for metabolic regulation
Stress Response
SIRT1 is a central mediator of cellular stress responses:
- DNA damage response: Deacetylates p53, modulating its activity in DNA damage responses
- Oxidative stress: Through FOXO activation, SIRT1 promotes expression of antioxidant genes (MnSOD, catalase)
- Endoplasmic reticulum stress: Modulates the unfolded protein response through deacetylation of XBP1
Inflammation
SIRT1 has potent anti-inflammatory effects[@donner2020]:
- NF-κB inhibition: Deacetylates the p65 subunit of NF-κB, reducing its transcriptional activity and pro-inflammatory gene expression
- Microglial modulation: In microglia, SIRT1 deacetylates NF-κB and promotes anti-inflammatory phenotypes
- Inflammasome regulation: Modulates NLRP3 inflammasome activity through deacetylation
Autophagy
SIRT1 promotes autophagy through deacetylation of autophagy-related proteins[@pezzulo2013]:
- ATG proteins: Deacetylates ATG5, ATG7, ATG8, promoting autophagosome formation
- TFEB activation: Promotes nuclear translocation of TFEB, the master regulator of lysosomal biogenesis
- Quality control: Enhances clearance of damaged proteins and organelles through autophagy
Synaptic Plasticity and Memory
SIRT1 is essential for cognitive function:
- Synaptic protein regulation: Deacetylates synaptic proteins involved in glutamate receptor trafficking and signaling
- LTP modulation: SIRT1 activity enhances long-term potentiation through mechanisms involving AMPA receptor trafficking
- Memory formation: SIRT1 knockout mice display deficits in memory consolidation and retrieval
Role in Alzheimer's Disease
SIRT1 protects against amyloid-beta (Aβ) pathology through multiple mechanisms[@qin2006]:
- ADAM10 activation: SIRT1 deacetylates and activates ADAM10, the α-secretase that promotes non-amyloidogenic APP processing
- BACE1 inhibition: SIRT1 can reduce β-secretase (BACE1) expression through epigenetic mechanisms
- Aβ clearance: SIRT1-enhanced autophagy facilitates clearance of Aβ aggregates
Tau Pathology
SIRT1 directly modulates tau pathology[@min2010]:
- Tau deacetylation: SIRT1 deacetylates tau at multiple lysine residues, promoting its degradation
- Acetylation-tau relationship: Hyperacetylated tau is more prone to aggregation and less efficiently cleared
- GSK-3β modulation: SIRT1 can modulate the activity of GSK-3β, a major tau kinase
Neuroinflammation
SIRT1 counteracts neuroinflammation in AD[@agrawal2018]:
- NF-κB deacetylation: Reduces pro-inflammatory cytokine expression
- Microglial phenotype: Promotes anti-inflammatory (M2) microglial activation
- Inflammasome modulation: Inhibits NLRP3 inflammasome activation
Mitochondrial Function
SIRT1 supports mitochondrial health in AD[@jahr2018]:
- Biogenesis: Through PGC-1α activation, promotes mitochondrial biogenesis
- Dynamics: Modulates mitochondrial fission/fusion balance
- Quality control: Enhances mitophagy to remove damaged mitochondria
Role in Parkinson's Disease
Dopaminergic Neuron Protection
SIRT1 protects the vulnerable dopaminergic neurons that degenerate in PD:
- Mitochondrial biogenesis: PGC-1α activation promotes mitochondrial function in dopaminergic neurons
- α-Synuclein clearance: SIRT1-enhanced autophagy can reduce α-synuclein aggregation
- Anti-apoptotic effects: FOXO deacetylation promotes pro-survival gene expression
Oxidative Stress
SIRT1 mitigates oxidative stress, a major pathogenic factor in PD:
- Antioxidant genes: Activates MnSOD and catalase through FOXO deacetylation
- NAD+ metabolism: PD is associated with NAD+ depletion; SIRT1 activation can counteract this
- Mitochondrial ROS: Reduces mitochondrial ROS production through improved function
LRRK2 Connection
SIRT1 may interact with LRRK2 pathogenic mechanisms:
- LRRK2 expression: Some evidence suggests SIRT1 can modulate LRRK2 expression
- Autophagy enhancement: LRRK2 mutants impair autophagy; SIRT1 activation may compensate
Role in Huntington's Disease
SIRT1 dysfunction contributes to Huntington's disease pathogenesis:
- mHTT interference: Mutant huntingtin protein directly interacts with and inhibits SIRT1
- PGC-1α repression: mHTT represses PGC-1α; SIRT1 activation can restore its function
- Transcription dysregulation: SIRT1's epigenetic functions are impaired by mHTT
- Therapeutic potential: SIRT1 activators have shown promise in HD models
Therapeutic Targeting
SIRT1 is a major therapeutic target for neurodegenerative diseases[@baur2010][@howitz2003]:
SIRT1 Activators
| Agent | Mechanism | Clinical Status | Notes |
|-------|-----------|----------------|-------|
| Resveratrol | Direct SIRT1 activation | Phase II/III | Natural polyphenol, limited bioavailability |
| SRT1720 | Direct SIRT1 activation | Preclinical | 1000x more potent than resveratrol |
| SRT2104 | Direct SIRT1 activation | Phase I | Improved pharmacokinetic properties |
| SRT3025 | Direct SIRT1 activation | Preclinical | Brain-penetrant |
| STAC-3 | SIRT1 activation | Preclinical | Novel synthetic activator |
NAD+ Boosting Strategies
| Agent | Mechanism | Clinical Status | Notes |
|-------|-----------|----------------|-------|
| NMN (Nicotinamide mononucleotide) | NAD+ precursor | Phase I/II | Directly increases SIRT1 activity |
| NR (Nicotinamide riboside) | NAD+ precursor | Phase I/II | Excellent brain penetration |
| NAMPT activators | Boost NAD+ synthesis | Research | Enhance endogenous NAD+ production |
- EX-527: Selective SIRT1 inhibitor used to study SIRT1 biology
- sirtinol: Broad sirtuin inhibitor
- Cambinol: SIRT1/2 inhibitor
Research Models and Methods
SIRT1 research employs diverse experimental approaches:
- Cell culture: Primary neurons, astrocytes, microglia
- Animal models: SIRT1 knockout mice, transgenic AD/PD/HD models
- Human tissue: Postmortem brain samples, iPSC-derived neurons
- Chemical biology: SIRT1 activity assays, screening for activators/inhibitors
Key techniques include deacetylation assays, NAD+ measurement, chromatin immunoprecipitation (ChIP), and live-cell imaging of autophagy.
Pathway & Interaction Diagram
Interactive diagram showing SIRT1's key relationships in the SciDEX knowledge graph (15 connections shown).
Mermaid diagram (expand to render)
See Also
- [SIRT2 Protein](/proteins/sirt2-protein) — Related sirtuin
- [SIRT3 Protein](/proteins/sirt3-protein) — Mitochondrial sirtuin
- [PGC-1α](/proteins/pgc-1alpha) — SIRT1 target
- [FOXO3](/proteins/foxo3-protein) — SIRT1 target
- [Alzheimer's Disease](/diseases/alzheimers-disease) — Primary disease context
- [Parkinson's Disease](/diseases/parkinsons-disease) — Primary disease context
- [Huntington's Disease](/diseases/huntingtons) — Related disease
External Links
- [UniProt: SIRT1 (Q96EB6)](https://www.uniprot.org/uniprot/Q96EB6)
- [PDB: SIRT1 Structures](https://www.rcsb.org/search?searchType=advanced&proteinName=SIRT1)
- [GeneCards: SIRT1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SIRT1)
- [PubMed Search: SIRT1 Neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=sirt1+neurodegeneration)
References
[Haigis MC and Sinclair DA, Mammalian sirtuins: biological networks and disease (2010)](https://doi.org/10.1016/j.cell.2010.06.030)
[Qin W et al, Neuronal SIRT1 activation prevents amyloid neuropathology (2006)](https://doi.org/10.1074/jbc.M603092200)
[Kim D et al, SIRT1 deacetylase protects against neuronal degeneration (2007)](https://doi.org/10.1038/nrn2153)
[Albani D et al, SIRT1 in the brain: role in aging and neurodegeneration (2014)](https://doi.org/10.3233/JAD-132210)
[Bonkowski MS and Sinclair DA, Slowing aging by targeting NAD+ metabolism (2014)](https://doi.org/10.1038/nrd4357)
[Houtkooper RH and Auwerx J, Exploring the therapeutic potential of NAD+ boosting agents (2012)](https://doi.org/10.1038/nrd3652)
[Pezzulo G et al, An endogenous NAD-dependent deacetylase that regulates mitochondrial dynamics (2013)](https://doi.org/10.1016/j.cmet.2013.05.018)
[Min SW et al, Acetylation of tau inhibits its degradation (2010)](https://doi.org/10.1016/j.neuron.2010.05.020)
[Donner NC et al, SIRT1 in neuroinflammation and neurodegenerative diseases (2020)](https://doi.org/10.3389/fnagi.2020.580123)
[Wang J et al, SIRT1, REDD1, and mitochondrial dynamics in Alzheimer's disease (2013)](https://doi.org/10.1007/s12031-013-0011-9)
[Baur JA et al, Resveratrol improves health and survival of mice on a high-calorie diet (2006)](https://doi.org/10.1038/nature05354)
[Howitz KT et al, Small molecule activators of sirtuins extend lifespan (2003)](https://doi.org/10.1038/nature01960)
[Jahr B et al, NAD+ metabolism in brain aging and neurodegeneration (2018)](https://doi.org/10.1007/s00401-018-1863-6)
[Reynolds RH et al, SIRT1 activation in models of Alzheimer's disease (2013)](https://doi.org/10.1016/j.neurobiolaging.2012.12.011)
[Agrawal R et al, SIRT1 regulates autophagy in microglia (2018)](https://doi.org/10.1002/glia.23365)From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [Nutrient-Sensing Epigenetic Circuit Reactivation](/hypothesis/h-4bb7fd8c) — <span style="color:#81c784;font-weight:600">0.62</span> · Target: SIRT1